Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19360135 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| Chloromethane SCHEMBL5155285 | 0.79 | CD81 (0.31) | — | |
| SCHEMBL14490234 | 0.79 | CYP1A2 (0.31) | — | |
| SCHEMBL10896901 | 0.78 | CD81 (0.33) | — | |
| SCHEMBL22346 | 0.78 | CD81 (0.33) | — | |
| SCHEMBL23530327 | 0.76 | TDP1 (0.32) | — | |
| Trimethylammonium SCHEMBL17512955 | 0.76 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL2064601 | 0.76 | TDP1 (0.32) | — | |
| Trimethylammonium SCHEMBL8742135 | 0.76 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL20893348 | 0.74 | ALDH1A1 (0.32) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230340012-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | PACIFIC ARROW LTD (CN) | 2023-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230340012-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | TEK, VCAM1, MCL1 | ALDH1A1 1090/4885TSHR 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.